Health Care/Hospital

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

PneumoBlast™ Reduces Pathology and Lung Fluid Accumulation in Model of COVID-19 HOUSTON, May 21, 2020 /PRNewswire/ -- FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19.  Mice immune systems were stimulate...

2020-05-21 22:03 2179

100+ Experts Identified Top Threats and Opportunities for Global Health Just Before COVID-19 Emerged as the First Test of the Medicines Supply Chain

New U.S. Pharmacopeia and MIT Center for Collective Intelligence report examines outlook for the future of medical breakthroughs ROCKVILLE, Md., May 21, 2020 /PRNewswire/ -- Just a few weeks before the first cases of COVID-19 were made public, a group of more than 100 leaders in health and medici...

2020-05-21 20:32 429

Ally Bridge Group Leads US$150 million Financing for Three U.S. Companies Amidst the COVID-19 Pandemic

NEW YORK and HONG KONG, May 21, 2020 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it led three investments in the U.S. -- two medtech and one telehealth -- in April, 2020 amidst the COVID-19 pandemic. Each of the three companies is ...

2020-05-21 20:00 9282

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme

SHANGHAI, GAITHERSBURG, Md. and SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medi...

2020-05-21 20:00 5696

111, Inc. Announces First Quarter 2020 Unaudited Financial Results

SHANGHAI, May 21, 2020 /PRNewswire/ --111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2020. First Quarter 2020 Hi...

2020-05-21 16:30 11040

Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

STOCKHOLM, May 21, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated...

2020-05-21 16:18 2143

Shun Tak committed to standing as one with Singapore through the largest mask donation to date

SINGAPORE, May 21, 2020 /PRNewswire/ -- Shun Tak Residential Development Pte Ltd, joined by Perennial Real Estate Holdings Limited, has donated 5 million face masks to the National Council of Social Services inSingapore through Community Chest Singapore as part of the "Partnerships for good" camp...

2020-05-21 14:26 3789

Dr Ivan Puah, Medical Director Of Amaris B. Clinic, Observes Positive Correlation Between Stress, Weight Gain And Physical Body Pain

SINGAPORE, May 21, 2020 /PRNewswire/ -- The COVID-19 pandemic has disrupted the lives and livelihood of many people. It has caused insecurities, anxiety and a feeling of helplessness among those affected. All these and more increase stress levels and if not managed well can lead to a multitude...

2020-05-21 14:12 3506

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

SEATTLE, May 21, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership withTakara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, wit...

2020-05-21 14:00 3416

Thailand's top retail developer, Central Pattana pushes its strategic plan 'Reunite Thailand Together' to move the country forward while pioneering to keep shoppers safe from COVID

BANGKOK, May 21, 2020 /PRNewswire/ -- Central Pattana (CPN), Thailand's leader in shopping center and property development with its 33 malls nationwide under brands centralwOrld, CentralPlaza, CentralFestival,Central Phuket, and Central Village,Thailand's first luxury outlet, pioneers  proactive ...

2020-05-21 12:01 4517

Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions

SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purcha...

2020-05-21 12:00 13908

Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT'

SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18th. ...

2020-05-21 10:03 3848

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology

MELBOURNE, Austrilia and SAN FRANCISCO, May 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has presented data on ATH434 (formerly PBT434) for the treatment of Multiple System Atrophy at the American Academy of Neurology (AAN) virtual meeting....

2020-05-21 08:58 5989

China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan"), China Biolog...

2020-05-21 04:45 11214

China Biologic Reports Financial Results for the First Quarter of 2020

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the first quarter of 2020. First Quarter ...

2020-05-21 04:30 10524

Kitchen Brains® launches USA2020 with $1+ million investment in Connecticut factory

STRATFORD, Connecticut, May 21, 2020 /PRNewswire/ -- Kitchen Brains has launched USA2020, an extensive program that includes an investment of more than $1 million in new, state-of-the art manufacturing equipment, clean kitchen products to support foodservice operators in today's coronavirus enviro...

2020-05-21 04:22 2893

VeChain and I-Dante Co-developed E-HCert, A Blockchain-based COVID-19 Records App For the Citizens of Cyprus

SHANGHAI, May 20, 2020 /PRNewswire/ -- With the pandemic putting healthcare systems under strain worldwide, Electronic Health Record (EHR) systems are also shifting requirements for data security and sharing. As the leading public blockchain platform, VeChain furthers the collaboration with I-Dan...

2020-05-20 23:00 6132

Havas Health & You Appoints Icaro Doria As Global Chief Creative Officer

Highly decorated Doria brings new global creative vision to the expanding network NEW YORK, May 20, 2020 /PRNewswire/ -- Havas Health & You (HH&Y) announces today the appointment ofIcaro Doria as Global Chief Creative Officer for the network. In his new role, Icaro will drive the vision and stra...

2020-05-20 21:59 2097

Macrogen Approved for Export of its COVID-19 Test Kit

SEOUL, South Korea, May 20, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18th. ...

2020-05-20 21:00 1757

CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

* Precision NanoSystems to Prese CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology * Precision NanoSystems will lead RNA vaccine formulation development * CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trial...

2020-05-20 21:00 2657
1 ... 678679680681682683684 ... 808